(5-Benzo[1,3]dioxol-5-yl-1-carbamoylmethyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-carbamic acid benzyl ester | 645059-74-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯二氮卓类
• 英文名称: (5-Benzo[1,3]dioxol-5-yl-1-carbamoylmethyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-carbamic acid benzyl ester
• CAS: 645059-74-1
• 化学式: C₂₆H₂₂N₄O₆
• 分子量: 486.484
• InChiKey: WSRWIJAYEMXVTE-UHFFFAOYSA-N

反应信息

• 作为反应物：
  描述：

  (5-Benzo[1,3]dioxol-5-yl-1-carbamoylmethyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 在 氢溴酸 、 1-羟基苯并三唑 、 溶剂黄146 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 (S)-N-((S)-5-Benzo[1,3]dioxol-5-yl-1-carbamoylmethyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-(3,4-difluoro-phenyl)-2-methyl-propionamide
  参考文献：
  名称：

  High affinity, bioavailable 3-Amino-1,4-benzodiazepine-Based γ-Secretase inhibitors

  摘要：

  In this paper, we describe the development of a novel series of high affinity, orally bioavailable 3-amino-1,4 benzodiazepine-based gamma-secretase inhibitors for the potential treatment of Alzheimer's disease. We disclose structure-activity relationships based around the 1, 3 and 5 positions of the benzodiazepine core structure. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.07.031
• 作为产物：
  描述：

  (5-benzo[1,3]dioxol-5-yl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 、 alkaline earth salt of/the/ methylsulfuric acid 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 (5-Benzo[1,3]dioxol-5-yl-1-carbamoylmethyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-carbamic acid benzyl ester
  参考文献：
  名称：

  High affinity, bioavailable 3-Amino-1,4-benzodiazepine-Based γ-Secretase inhibitors

  摘要：

  In this paper, we describe the development of a novel series of high affinity, orally bioavailable 3-amino-1,4 benzodiazepine-based gamma-secretase inhibitors for the potential treatment of Alzheimer's disease. We disclose structure-activity relationships based around the 1, 3 and 5 positions of the benzodiazepine core structure. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.07.031